lapachol has been researched along with amphotericin b in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iida, A; Kaneko, M; Kumeda, Y; Nishimura, K; Tokuda, H; Yamashita, M | 1 |
Alves, CL; Araújo, IAC; de Paula, RC; Dias, EMFA; Faria, KF; Mendes, GG; Oliveira, AB; Oliveira, MM; Ribeiro, RR; Silva, SMD | 1 |
2 other study(ies) available for lapachol and amphotericin b
Article | Year |
---|---|
Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Mice; Microbial Sensitivity Tests; Naphthoquinones; Plants, Medicinal; Stereoisomerism; Tabebuia | 2009 |
Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Flow Cytometry; Hep G2 Cells; Humans; Inhibitory Concentration 50; Leishmania infantum; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Naphthoquinones; Parasite Load; Plant Extracts; Random Allocation; RAW 264.7 Cells; Skin; Spleen; Tabebuia | 2019 |